Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab

Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab

Abstract The early remission of diabetic macular edema (DME) often occurs in eyes treated with anti-vascular endothelial growth factor (VEGF) treatment. We retrospectively reviewed and characterized eyes with early remission of DME at six months in 80 eyes under pro re nata (PRN) intravitreal ranibi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tatsuya Yoshitake, Tomoaki Murakami, Kiyoshi Suzuma, Masahiro Fujimoto, Yoko Dodo, Akitaka Tsujikawa
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/4e45db775cc64c1a91f4546776fa7729
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares